David G. Maloney

David Maloney practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

David Maloney's NPI, 1942385752, was assigned on October 27, 2006. David Maloney graduated from Stanford University School of Medicine in 1985. David Maloney holds Washington license MD00032212.

David Maloney's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

David Maloney's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. David Maloney is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where David Maloney practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is David Maloney's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. David Maloney is licensed in Washington.

CMS data shows 46 Medicare services from David Maloney across 1 procedure code in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $2,951 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw David Maloney in 2024. The largest group is 65 to 74, with 27 patients. 60% of them have high blood pressure, and 51% have high cholesterol. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Maloney's median patient age at 73, with 43% women.

In 2024, David Maloney wrote 21 Medicare Part D claims. They cover 3 drugs, with $660,066 in total drug cost. In 2020, CMS named 78 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for David Maloney for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 115 papers to David Maloney, published from 2015 to 2025. 2019 was the busiest year, with 14. The most frequent topics are Immunotherapy, Adoptive, Receptors, Chimeric Antigen and Receptors, Antigen, T-Cell. David Maloney has published most often in Blood. David Maloney's most frequent co-authors are Cameron John Turtle, MBBS, PhD, Mazyar Shadman, MD, MPH and Stanley R. Riddell, MD.

CMS Open Payments shows 196 general payments to David Maloney from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Celgene Corporation paid the most, $61,914. It also lists 8 research payments totaling $9,270 from 2016 to 2025.

David Maloney graduated from Stanford University School of Medicine in 1985.